{"id":5030,"date":"2025-04-04T18:03:34","date_gmt":"2025-04-04T15:03:34","guid":{"rendered":"https:\/\/hypersense-software.com\/blog\/?p=5030"},"modified":"2025-11-13T20:25:49","modified_gmt":"2025-11-13T18:25:49","slug":"navigating-fda-compliance-ai-healthcare-ehrs","status":"publish","type":"post","link":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/","title":{"rendered":"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_80 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Understanding_FDA_Regulations_for_AI_in_Healthcare_and_EHRs\" >Understanding FDA Regulations for AI in Healthcare and EHRs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Does_Your_AI_Count_as_a_Medical_Device\" >Does Your AI Count as a Medical Device?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Device_classifications_Class_I_II_III_and_pathways\" >Device classifications (Class I, II, III) and pathways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Key_FDA_frameworks_and_guidance_for_AIML_software\" >Key FDA frameworks and guidance for AI\/ML software<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Software_as_a_Medical_Device_SaMD\" >Software as a Medical Device (SaMD)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Clinical_Decision_Support_CDS_Guidance\" >Clinical Decision Support (CDS) Guidance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#AIML_Modification_Framework\" >AI\/ML Modification Framework<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Good_Machine_Learning_Practice_GMLP\" >Good Machine Learning Practice (GMLP)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Post-Market_Monitoring\" >Post-Market Monitoring<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Case_Studies\" >Case Studies<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Success_Story_How_IDx-DR_Achieved_FDA_Compliance\" >Success Story: How IDx-DR Achieved FDA Compliance<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#How_Idx-DR_Got_FDA_Approval\" >How Idx-DR Got FDA Approval<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#What_the_FDA_Looked_For\" >What the FDA Looked For<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Why_IDx-DR_Succeeded\" >Why IDx-DR Succeeded<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#The_Takeaway\" >The Takeaway<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Compliance_Failure_The_Mistakes_of_IBM_Watson_for_Oncology\" >Compliance Failure: The Mistakes of IBM Watson for Oncology<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#What_Went_Wrong\" >What Went Wrong<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#The_Core_Issues_Behind_Watsons_Failure\" >The Core Issues Behind Watson\u2019s Failure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Lessons_Learned_from_Watson_for_Oncology\" >Lessons Learned from Watson for Oncology<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#The_Takeaway-2\" >The Takeaway<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Practical_Compliance_Strategies_and_Best_Practices\" >Practical Compliance Strategies and Best Practices<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#For_Healthcare_Administrators_Hospitals_Clinics_IT_Managers\" >For Healthcare Administrators (Hospitals, Clinics, IT Managers)<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Check_The_Wanted_Product\" >Check The Wanted Product<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Know_the_AIs_Intended_Use_and_Its_Limits\" >Know the AI\u2019s Intended Use and Its Limits<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Train_the_Team_on_How_to_Use_AI_Effectively\" >Train the Team on How to Use AI Effectively<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Monitor_Performance_and_Report_Issues\" >Monitor Performance and Report Issues<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Stay_Up_to_Date_on_Changing_Regulations\" >Stay Up to Date on Changing Regulations<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#For_Healthcare_Innovators_and_Developers_R_D_Teams_Clinical_AI_Researchers\" >For Healthcare Innovators and Developers (R&amp;D Teams, Clinical AI Researchers)<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Identify_Regulatory_Requirements_Early\" >Identify Regulatory Requirements Early<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Design_with_Quality_and_Regulations_in_Mind\" >Design with Quality and Regulations in Mind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Incorporate_Good_Machine_Learning_Practice_GMLP\" >Incorporate Good Machine Learning Practice (GMLP)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Engage_with_FDA_and_Experts\" >Engage with FDA and Experts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Align_Your_Product_Claims_with_Regulations\" >Align Your Product Claims with Regulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Plan_for_Post-Market_Updates\" >Plan for Post-Market Updates<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#For_Healthcare_Startups_Entrepreneurs_in_Digital_Health\" >For Healthcare Startups (Entrepreneurs in Digital Health)<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Make_Compliance_Part_of_Your_Business_Plan\" >Make Compliance Part of Your Business Plan<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-37\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Set_Up_a_Quality_System_From_Day_One\" >Set Up a Quality System From Day One<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-38\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Leverage_Guidance_and_Predicate_Devices\" >Leverage Guidance and Predicate Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-39\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Conduct_User-Centric_and_Clinical_Testing\" >Conduct User-Centric and Clinical Testing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-40\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Be_Honest_and_Transparent_in_Your_Marketing\" >Be Honest and Transparent in Your Marketing<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-41\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Compliance_as_a_Pathway_to_Innovation\" >Compliance as a Pathway to Innovation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-42\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#Key_Takeaways\" >Key Takeaways<\/a><\/li><\/ul><\/nav><\/div>\n\n<p><strong>FDA compliance<\/strong> is a critical stepping stone in the rapidly evolving landscape of AI-driven healthcare tools and electronic health records (EHRs). Artificial intelligence is revolutionizing the medical field in ways that seemed impossible a decade ago\u2014through advanced predictive analytics, AI-driven diagnostics, and more. <\/p>\n\n\n\n<p>Yet, with this extraordinary potential comes an urgent need for clear regulatory frameworks to ensure that these technologies serve the greater good safely and effectively. The U.S. Food and Drug Administration (FDA) plays a pivotal role here, requiring developers and healthcare organizations alike to meet rigorous standards of safety and effectiveness. <\/p>\n\n\n\n<p>This guide demystifies those standards, offering real-world examples and actionable insights for anyone navigating FDA compliance in AI healthcare.<\/p>\n\n\n<div class=\"post-cta\"><div><div><p class=\"blog-cta-title\">Experience Expert IT Consultancy<\/p><p>Transformative Strategies for Your Technology Needs<\/p><a href=\"https:\/\/hypersense-software.com\/services\/it-consultancy\">Discover IT Consulting<\/a><\/div><\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-understanding-fda-regulations-for-ai-in-healthcare-and-ehrs\"><span class=\"ez-toc-section\" id=\"Understanding_FDA_Regulations_for_AI_in_Healthcare_and_EHRs\"><\/span>Understanding FDA Regulations for AI in Healthcare and EHRs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-does-your-ai-count-as-a-medical-device-nbsp\"><span class=\"ez-toc-section\" id=\"Does_Your_AI_Count_as_a_Medical_Device\"><\/span>Does Your AI Count as a Medical Device?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The FDA has a broad definition of a <strong>medical device<\/strong>. It\u2019s not just physical instruments like pacemakers or MRI machines\u2014certain types of software can also qualify. If your AI is designed to diagnose, prevent, or treat a disease, there\u2019s a good chance it falls under FDA oversight.<\/p>\n\n\n\n<p>That being said, not <strong>all<\/strong> health-related software is regulated. Thanks to the <strong>21st Century<\/strong> <strong>Cures Act<\/strong>, some software functions\u2014like scheduling, billing, or simple wellness tracking\u2014are exempt. A basic EHR that just stores patient data? Likely unregulated. But if that EHR has an AI module that analyzes medical data and suggests treatment options? Now, this falls in FDA territory.<\/p>\n\n\n\n<p>The key question is: <strong>Does the software influence clinical decisions<\/strong>? If the answer is yes\u2014especially if the AI provides autonomous recommendations\u2014the FDA will likely require compliance.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-device-classifications-class-i-ii-iii-and-pathways\"><span class=\"ez-toc-section\" id=\"Device_classifications_Class_I_II_III_and_pathways\"><\/span>Device classifications (Class I, II, III) and pathways<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>After determining your AI product needs FDA regulation, you must identify which category the FDA assigns to it. The agency organizes medical devices into three distinct categories.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Class I <\/strong>means low-risk devices (e.g., medical gloves, simple diagnostic tools). The majority of devices fall into this category, meaning that they do not require premarket review.<\/li>\n\n\n\n<li>Medical devices classified as <strong>Class II <\/strong>include AI-powered diagnostic imaging tools. The 510(k) clearance process demonstrates that new devices are equivalent to those already approved by the FDA.<\/li>\n\n\n\n<li>The FDA categorizes devices into three risk levels, with <strong>Class III<\/strong> comprising life-sustaining AI systems used for robotic surgeries. Full Premarket Approval (PMA) requires these devices to undergo extensive clinical trials.<\/li>\n<\/ul>\n\n\n\n<p>AI-based medical software generally receives the FDA\u2019s Class II designation unless it independently makes critical medical decisions, which would elevate its classification to Class III. The approval process is contingent on the classification assigned to the medical software.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>510(k) Clearance<\/strong> \u2013 The most common route for Class II devices. Through this approval pathway, companies demonstrate that their AI tool meets or exceeds the performance standards of established FDA-approved products, referred to as predicates. The approval process via 510(k) Clearance is quick, and while clinical trials are generally not required, it poses challenges for AI because the system was designed for traditional medical devices.<\/li>\n\n\n\n<li><strong>De Novo Classification<\/strong> is used to approve new devices that lack established FDA precedents. A new device category results from this pathway when an AI system is the first device of its kind, allowing future similar devices to obtain 510(k) approval more efficiently.<\/li>\n\n\n\n<li><strong>Premarket Approval (PMA)<\/strong> is the most rigorous process that applies to high-risk AI systems responsible for life-saving decisions. This process necessitates extensive clinical testing, resulting in only a few AI tools successfully completing this step. In the future, we can expect more widespread PMA applications for AI healthcare systems as they begin to handle increasingly critical medical choices.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-key-fda-frameworks-and-guidance-for-ai-ml-software\"><span class=\"ez-toc-section\" id=\"Key_FDA_frameworks_and_guidance_for_AIML_software\"><\/span>Key FDA frameworks and guidance for AI\/ML software<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The FDA recognizes that regulations for medical devices need updates to address the rapid advancements in artificial intelligence technology, so they have introduced new guidelines. They have established several fundamental guidelines to ensure the safety and effectiveness of AI-driven healthcare tools.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-software-as-a-medical-device-samd\"><span class=\"ez-toc-section\" id=\"Software_as_a_Medical_Device_SaMD\"><\/span>Software as a Medical Device (SaMD)<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Not all healthcare software is subject to strict regulation. The FDA adheres to the <strong>International Medical Device Regulators Forum (IMDRF)<\/strong> definition of <strong>Software as a Medical Device (SaMD)<\/strong>, which encompasses many AI tools. Basic electronic health record (EHR) systems that merely store or transfer patient data are typically low-risk and may not require extensive oversight. However, when AI begins analyzing medical data and influencing decisions, the FDA imposes stricter regulations.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-clinical-decision-support-cds-guidance\"><span class=\"ez-toc-section\" id=\"Clinical_Decision_Support_CDS_Guidance\"><\/span>Clinical Decision Support (CDS) Guidance<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The FDA has clarified how <strong>clinical decision support (CDS) software<\/strong> is regulated. If an AI tool merely assists doctors\u2014such as by reminding them of medical guidelines\u2014it might not require FDA approval. However, if it influences decisions or functions as an autonomous diagnostic tool (e.g., stating \u201cThis patient has Condition X\u201d without sufficient reasoning), it is probable that it will be classified as a regulated medical device.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-ai-ml-modification-framework\"><span class=\"ez-toc-section\" id=\"AIML_Modification_Framework\"><\/span>AI\/ML Modification Framework<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>One of the biggest challenges in AI regulation is that AI models continue to learn and evolve. Traditional FDA approvals do not consider this since most medical devices remain static once they are approved. To address this, the FDA introduced a framework that allows pre-approved AI updates through a <strong>Predetermined Change Control Plan (PCCP).<\/strong> This means that if a company outlines expected AI model updates in advance\u2014such as retraining the model with new data\u2014the FDA can approve them prior to implementation, thus reducing the need for constant re-approvals. In 2021, the FDA released an AI\/ML&nbsp;<em>Action Plan<\/em>&nbsp;and, in 2023, a draft guidance on PCCPs, signaling how future regulations will accommodate continuously-learning AI algorithms.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-good-machine-learning-practice-gmlp\"><span class=\"ez-toc-section\" id=\"Good_Machine_Learning_Practice_GMLP\"><\/span>Good Machine Learning Practice (GMLP)<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The FDA, along with regulatory agencies, has established <strong>Good Machine Learning Practice (GMLP)<\/strong> as best practices for AI in healthcare. These guidelines focus on ensuring high-quality training data, monitoring AI performance over time, promoting transparency in AI decision-making, and avoiding bias in AI models.<\/p>\n\n\n\n<p>When AI tools operate without proper safeguards, they can deliver incorrect or potentially dangerous treatment recommendations, as previously noted by the FDA. The implementation of GMLP allows developers to create models that regulators can trust because they show reliability.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-post-market-monitoring\"><span class=\"ez-toc-section\" id=\"Post-Market_Monitoring\"><\/span>Post-Market Monitoring<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The FDA clearance process does not conclude since AI tools require ongoing monitoring. AI devices differ from standard medical equipment because they face actual clinical scenarios that testing did not predict. For this reason, the FDA dedicates its efforts to post-market surveillance. Manufacturers are expected to monitor their AI systems during actual medical practice to track performance outcomes, collect feedback from users, and respond to all safety issues that emerge during product use. They must provide software updates together with product recalls when necessary.<\/p>\n\n\n\n<p>AI devices that obtain 510(k) clearance need special monitoring because they typically lack results from complete clinical trials. Post-launch performance monitoring functions as a protective mechanism to identify and remedy any problems that may occur.<\/p>\n\n\n\n<p>Therefore, based on the FDA framework, the first step in developing an AI-powered healthcare tool or advanced EHR feature is to determine whether the system requires FDA regulation. The next step involves selecting the appropriate regulatory pathway based on risk level while following the FDA\u2019s evolving AI guidance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-case-studies\"><span class=\"ez-toc-section\" id=\"Case_Studies\"><\/span>Case Studies<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-success-story-how-idx-dr-achieved-fda-compliance\"><span class=\"ez-toc-section\" id=\"Success_Story_How_IDx-DR_Achieved_FDA_Compliance\"><\/span>Success Story: How IDx-DR Achieved FDA Compliance<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>IDx-DR represents a pivotal success story of AI-based healthcare because it uses artificial intelligence to detect diabetic retinopathy, a severe eye disease that threatens blindness for untreated patients. Doctors traditionally needed to study retinal images with great attention to identify diabetic retinopathy. The IDx-DR team developed an AI system to <strong>automate<\/strong> disease detection after recognizing the need to change current diagnostic practices.<\/p>\n\n\n\n<p>IDx-DR achieved a landmark milestone in AI-driven healthcare when the FDA authorized it as the first AI diagnostic device that did not require human interpretation of results in 2018. However, reaching that point was not easy. The team faced stringent FDA regulations while <strong>pioneering<\/strong> the regulatory process for an AI diagnostic tool, as no similar tools had previously received FDA approval.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-how-idx-dr-got-fda-approval\"><span class=\"ez-toc-section\" id=\"How_Idx-DR_Got_FDA_Approval\"><\/span>How Idx-DR Got FDA Approval<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The IDx-DR team acknowledged that their product would be designated as a medical device from the beginning, which made FDA compliance a necessary requirement. Since no predicate device existed, the team needed to pursue a De Novo pathway, which is a pathway for revolutionary medical technologies.<\/p>\n\n\n\n<p>The AI accuracy and safety assessment clinical trial included 900 patients distributed across 10 testing sites. The results were impressive:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The AI system demonstrated 87% accuracy in detecting diabetic retinopathy conditions worse than mild severity.<\/li>\n\n\n\n<li>The system proved accurate in excluding the disease from patients in 89% of tests.<\/li>\n<\/ul>\n\n\n\n<p>These results provided the FDA with evidence that IDx-DR performed at a level similar to that of human ophthalmologists, thus strengthening their case for approval.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-the-fda-looked-for\"><span class=\"ez-toc-section\" id=\"What_the_FDA_Looked_For\"><\/span>What the FDA Looked For<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>FDA clearance required more than accuracy validation since it demanded a precise definition of the AI system\u2019s limitations. The FDA evaluated all stages of IDx-DR software operations to prevent system misuse. For example:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The AI system should not evaluate patients who received eye treatments or have specific medical conditions because the training data did not include enough such cases.<\/li>\n\n\n\n<li>The system provided results in only two possible ways:\n<ul class=\"wp-block-list\">\n<li>\u201cMore than mild DR detected \u2013 refer to a specialist\u201d.<\/li>\n\n\n\n<li>\u201cNegative \u2013 rescreen in 12 months\u201d.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>The system had restrictions on making diagnoses only for diabetic retinopathy while excluding other eye conditions.<\/li>\n<\/ul>\n\n\n\n<p>The company maintained a narrow, well-defined scope for the tool, which allowed IDx-DR to remain in the moderate-risk category and expedited regulatory approval.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-why-idx-dr-succeeded\"><span class=\"ez-toc-section\" id=\"Why_IDx-DR_Succeeded\"><\/span>Why IDx-DR Succeeded<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>IDx-DR achieved success by excelling at meeting FDA requirements. From day one, the company prioritized FDA compliance instead of treating it as a secondary matter. Here\u2019s what they did right:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The company took an early approach to work with the FDA to establish precise requirements for data and evidence.<\/li>\n\n\n\n<li>The team developed an objective clinical trial to establish AI effectiveness.<\/li>\n\n\n\n<li>The software development process strictly followed quality standards to fulfill the requirements of medical device regulations.<\/li>\n\n\n\n<li>The AI&#8217;s developers defined its proper applications while preventing them from overstating its capabilities.<\/li>\n<\/ul>\n\n\n\n<p>The FDA approved IDx-DR, which then became available in the market as LumiScan. With its new functionality, the device enables primary care physicians to detect eye diseases in diabetic patients without specialist intervention.<\/p>\n\n\n<div class=\"post-cta\"><div><div><p class=\"blog-cta-title\">Cutting-Edge Custom Software Development for Your Success<\/p><p>Create Software That Meets Your Specific Requirements<\/p><a href=\"https:\/\/hypersense-software.com\/services\/custom-software-development\">Explore Custom Software<\/a><\/div><\/div><\/div>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-the-takeaway\"><span class=\"ez-toc-section\" id=\"The_Takeaway\"><\/span>The Takeaway<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The lengthy FDA regulatory journey leads to enhanced product safety and boosts confidence among both medical professionals and patients regarding the product. The IDx-DR achievement serves as a model for all AI healthcare tools seeking FDA approval, as developers need to devise their strategy with thorough preplanning and integrate proof of functionality and regulatory compliance before beginning.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-compliance-failure-the-mistakes-of-ibm-watson-for-oncology\"><span class=\"ez-toc-section\" id=\"Compliance_Failure_The_Mistakes_of_IBM_Watson_for_Oncology\"><\/span>Compliance Failure: The Mistakes of IBM Watson for Oncology<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Not every artificial intelligence healthcare innovation delivers successful outcomes. IBM Watson for Oncology is a prime example of a failed AI system that promised to help doctors treat cancer patients. The healthcare industry promoted Watson for Oncology as an advanced system that analyzed extensive medical research to provide optimal treatment recommendations for cancer patients.<\/p>\n\n\n\n<p>The main issue with this system was that it failed to obtain the necessary FDA approval. IBM described Watson as a medical decision tool that doctors could use for consultation but not as a standalone treatment solution. The regulatory classification prevented Watson for Oncology from undergoing the FDA&#8217;s stringent approval process, which would become a significant problem in the future.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-went-wrong\"><span class=\"ez-toc-section\" id=\"What_Went_Wrong\"><\/span>What Went Wrong<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>IBM&#8217;s healthcare AI Watson received billions of dollars to undergo specialized training from leading cancer centers while studying medical textbooks. However, information from 2018 revealed that Watson for Oncology provided unsafe and incorrect treatment choices to cancer patients.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The system recommended cancer treatments that ran against established medical protocol.<\/li>\n\n\n\n<li>An audit revealed that Watson prescribed medication to a bleeding-prone patient that no qualified oncologist would have recommended.<\/li>\n\n\n\n<li>The healthcare professionals stopped trusting the system after which several doctors reported that Watson lacked clinical value.<\/li>\n<\/ul>\n\n\n\n<p>Human medical professionals reviewed the AI recommendations, which prevented patients from being directly harmed by the flawed system. However, the discovery of these errors in Watson\u2019s AI system created substantial doubts about its training process and whether it was deployed prematurely.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-the-core-issues-behind-watson-s-failure\"><span class=\"ez-toc-section\" id=\"The_Core_Issues_Behind_Watsons_Failure\"><\/span>The Core Issues Behind Watson\u2019s Failure<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lack of Real-World Data<\/strong><\/li>\n<\/ul>\n\n\n\n<p>The public believed Watson for Oncology used thousands of genuine patient cases during training, yet most of its data came from hypothetical situations developed by IBM engineers and partner physicians. The system developed knowledge gaps, which resulted in essential mistakes during decision-making processes.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>No Independent Validation<\/strong><\/li>\n<\/ul>\n\n\n\n<p>A formal regulatory review process never evaluated FDA-approved medical devices, so Watson skipped this requirement. Because IBM lacked external oversight, hospitals did not need to show proof of accuracy and safety through clinical trials until they began implementing its system.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Opaque Decision-Making<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Medical professionals sometimes encountered unclear reasoning when Watson provided its treatment recommendations. The FDA requires medical decision tools to maintain transparency so providers can understand the reasons behind AI-based recommendation reasons. Watson&#8217;s unclear nature prevented healthcare professionals from easily detecting or correcting its mistakes.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Overpromising and Under-Delivering<\/strong><\/li>\n<\/ul>\n\n\n\n<p>IBM used its marketing to present Watson as an artificial intelligence capable of reading every medical publication to identify the best possible treatments, which generated excessive expectations. The AI&#8217;s actual capabilities fell short of expectations, and doctors and hospital staff lost their faith in it.<\/p>\n\n\n\n<p>In 2017, MD Anderson Cancer Center terminated its Watson program, which had cost the hospital millions of dollars. In 2021, IBM announced that it would dispose of its Watson Health division, ending its extensive AI healthcare project.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-lessons-learned-from-watson-for-oncology\"><span class=\"ez-toc-section\" id=\"Lessons_Learned_from_Watson_for_Oncology\"><\/span>Lessons Learned from Watson for Oncology<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>So, what can AI developers and healthcare innovators take away from this failure?<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Oversight Matters<\/strong>\u2014The absence of FDA oversight allowed Watson to escape regulatory review, which meant its deficiencies remained undetected until late in its development process. A formal FDA review process could have prevented some problems with the AI\u2019s deployment in hospitals.<\/li>\n\n\n\n<li><strong>Clinical Validation<\/strong> through real-world testing is necessary for AI systems that affect patient care. Watson&#8217;s hypothetical training data did not adequately prepare it to handle actual clinical scenarios.<\/li>\n\n\n\n<li><strong>Transparency Builds Trust<\/strong> &#8211; Doctors must fully understand all decisions made by AI systems to develop trust in their operations. Because transparency is absent, errors remain invisible until they trigger significant issues.<\/li>\n\n\n\n<li><strong>Excessive promotion<\/strong> of your AI will result in misuse, disappointment, and compliance issues. Underestimating what you can achieve leads to superior performance compared to promising too much.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-the-takeaway-0\"><span class=\"ez-toc-section\" id=\"The_Takeaway-2\"><\/span>The Takeaway<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The failure of IBM Watson for Oncology resulted in business losses and a warning signal for the entire AI healthcare industry. The absence of real-world validation and regulatory oversight when releasing AI tools quickly to market results in expensive failures and diminished user trust.<\/p>\n\n\n\n<p>Healthcare AI innovators need to understand that FDA compliance is a fundamental requirement for confirming that AI-driven tools deliver safety and effectiveness for patient benefit.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-practical-compliance-strategies-and-best-practices\"><span class=\"ez-toc-section\" id=\"Practical_Compliance_Strategies_and_Best_Practices\"><\/span>Practical Compliance Strategies and Best Practices<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Achieving FDA compliance can seem overwhelming, particularly for newcomers in the health tech field. However, by proactively incorporating regulatory considerations into your project, you can prevent costly mistakes and delays. Below are practical strategies and best practices designed for various stakeholders in the healthcare and health IT community:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-for-healthcare-administrators-hospitals-clinics-it-managers\"><span class=\"ez-toc-section\" id=\"For_Healthcare_Administrators_Hospitals_Clinics_IT_Managers\"><\/span>For Healthcare Administrators (Hospitals, Clinics, IT Managers)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-check-the-wanted-product\"><span class=\"ez-toc-section\" id=\"Check_The_Wanted_Product\"><\/span>Check The Wanted Product<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>You should verify the regulatory compliance of any AI-powered system before deploying it. Does the device have FDA clearance or approval for its intended use? Request the company to provide detailed explanations for their decision to bypass FDA approval procedures. Official documentation should be acquired to support all claims. Compliant tools that have undergone proper vetting serve as safeguards for organizational and patient safety.<\/p>\n\n\n<div class=\"post-cta\"><div><div><p class=\"blog-cta-title\">Accelerate Your Growth with Digital Transformation<\/p><p>Digital Excellence Through Customized Business Solutions<\/p><a href=\"https:\/\/hypersense-software.com\/services\/digital-transformation\">Explore Digital Transformation<\/a><\/div><\/div><\/div>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-know-the-ai-s-intended-use-and-its-limits\"><span class=\"ez-toc-section\" id=\"Know_the_AIs_Intended_Use_and_Its_Limits\"><\/span>Know the AI\u2019s Intended Use and Its Limits<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The AI tool should have clear boundaries that clinical staff must understand regarding its capabilities and limitations. When AI is misused, it poses severe risks to patient health. The FDA felt compelled to issue a warning because a stroke-detection AI system was used to diagnose patients, though its intended role was to assist triage, leading to potential misdiagnoses. Establishing defined rules and providing education to staff members helps prevent such errors.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-train-the-team-on-how-to-use-ai-effectively\"><span class=\"ez-toc-section\" id=\"Train_the_Team_on_How_to_Use_AI_Effectively\"><\/span>Train the Team on How to Use AI Effectively<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>AI systems achieve their maximum value through effective human utilization. Healthcare staff should use AI recommendations with caution. They should understand system operations and learn which situations require AI assistance and which demand human evaluation. AI functions as a support system that assists healthcare providers, so training programs must teach this essential distinction to staff. Staff members should report any AI outputs that differ from their clinical expertise to their supervisors.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-monitor-performance-and-report-issues\"><span class=\"ez-toc-section\" id=\"Monitor_Performance_and_Report_Issues\"><\/span>Monitor Performance and Report Issues<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Your responsibilities remain active after an AI system is approved by the FDA. AI tools require continuous surveillance for proper operational functionality. A reporting mechanism should enable medical staff to notify the system about incorrect results and abnormal patterns. Contact the vendor immediately when an AI system shows repeated errors in diagnosis or produces unnecessary warning signals and reconsider its implementation. You can also report serious issues to the FDA through their <strong>MedWatch program<\/strong>.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-stay-up-to-date-on-changing-regulations\"><span class=\"ez-toc-section\" id=\"Stay_Up_to_Date_on_Changing_Regulations\"><\/span>Stay Up to Date on Changing Regulations<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>AI regulations undergo continuous changes because they adapt to new developments in the field. The FDA reserves the right to establish fresh guidelines and make reclassification decisions for select AI tools, particularly within EHR contexts. Your facility can maintain regulatory compliance by following policy changes, industry developments, and compliance requirements. The compliance process requires continuous effort because it continues beyond the initial implementation.<\/p>\n\n\n\n<p>These implementation steps enable both AI implementation and safety as well as responsible usage of AI in healthcare facilities.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-for-healthcare-innovators-and-developers-r-amp-d-teams-clinical-ai-researchers\"><span class=\"ez-toc-section\" id=\"For_Healthcare_Innovators_and_Developers_R_D_Teams_Clinical_AI_Researchers\"><\/span>For Healthcare Innovators and Developers (R&amp;D Teams, Clinical AI Researchers)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Building AI for healthcare applications involves creating medical instruments that directly affect patient lives, regardless of your role in the development process. Implementing compliance standards becomes mandatory from the beginning of the development process, so you should integrate them early to achieve better results.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-identify-regulatory-requirements-early\"><span class=\"ez-toc-section\" id=\"Identify_Regulatory_Requirements_Early\"><\/span>Identify Regulatory Requirements Early<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>At the start of development, ask yourself whether your AI system meets medical device requirements. Software that generates treatment recommendations or diagnoses conditions will necessarily be subject to FDA medical device regulations. Understanding your product&#8217;s regulatory position early on prevents future time and money losses and regulatory complications.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-design-with-quality-and-regulations-in-mind\"><span class=\"ez-toc-section\" id=\"Design_with_Quality_and_Regulations_in_Mind\"><\/span>Design with Quality and Regulations in Mind<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The practice of good software engineering demands functionality as well as safety and reliability features. During development, ensure that you:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>All development stages must receive complete documentation from requirements through design until testing is complete.<\/li>\n\n\n\n<li>Quality control procedures must be implemented to maintain direct relationships between your development work and its underlying purposes.<\/li>\n\n\n\n<li>The FDA has found that software defects account for 20% of medical device recalls. Developers need to test their software rigorously, and a robust quality management system can assist your organization in preventing these problems.<\/li>\n<\/ul>\n\n\n\n<p>Incorporating compliance into your development workflow rather than treating it as a final step will simplify the FDA submission process.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-incorporate-good-machine-learning-practice-gmlp\"><span class=\"ez-toc-section\" id=\"Incorporate_Good_Machine_Learning_Practice_GMLP\"><\/span>Incorporate Good Machine Learning Practice (GMLP)<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>AI technology introduces distinct difficulties, mainly affecting bias, accuracy, and reliability performance. The FDA supports <strong>Good Machine Learning Practice (GMLP)<\/strong> through its guidelines that involve:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The avoidance of bias requires training with data from various sources.<\/li>\n\n\n\n<li>The system should undergo testing against real-world conditions and edge scenarios to guarantee its accuracy.<\/li>\n\n\n\n<li>Your AI development requires documentation of performance metrics, including sensitivity and specificity, to demonstrate its operational effectiveness.<\/li>\n<\/ul>\n\n\n\n<p>Regulators&#8217; review process requires documentation of your AI model&#8217;s safety and fairness, along with evidence of effectiveness, for approval purposes.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-engage-with-fda-and-experts\"><span class=\"ez-toc-section\" id=\"Engage_with_FDA_and_Experts\"><\/span>Engage with FDA and Experts<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The worst thing you can do is guess what the FDA wants and hope for the best. Instead, use the FDA\u2019s Q-Submission program to ask for feedback before you file. This gives you a chance to get non-binding advice on your regulatory strategy, make sure your planned testing and validation meet FDA expectations, and avoid wasting time going down the wrong compliance pathway.<\/p>\n\n\n\n<p>If your team isn\u2019t familiar with digital health regulations, hiring a regulatory affairs specialist can be a game-changer\u2014they will help ensure your FDA submission is airtight.<\/p>\n\n\n<div class=\"post-cta\"><div><div><p class=\"blog-cta-title\">Experience Our Research & Development Expertise<\/p><p>R&D-Led Software Development Integrates Innovation into Every Product Detail<\/p><a href=\"https:\/\/hypersense-software.com\/services\/research-development\">Learn About R&D Services<\/a><\/div><\/div><\/div>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-align-your-product-claims-with-regulations\"><span class=\"ez-toc-section\" id=\"Align_Your_Product_Claims_with_Regulations\"><\/span>Align Your Product Claims with Regulations<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>One of the quickest ways to encounter compliance issues is by overpromising what your AI can achieve. To steer clear of FDA oversight, you should position your tool thoughtfully\u2014 for instance, categorizing it as \u201cfor research purposes only\u201d or as &#8220;wellness\u201d software.<\/p>\n\n\n\n<p>If your AI is making medical decisions, trying to present it as an unregulated product can result in serious legal and regulatory repercussions. Be transparent about your AI\u2019s functions and obtain the necessary approvals\u2014it\u2019s preferable to handle everything correctly from the start than to face enforcement actions later.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-plan-for-post-market-updates\"><span class=\"ez-toc-section\" id=\"Plan_for_Post-Market_Updates\"><\/span>Plan for Post-Market Updates<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The evolution of AI presents a challenge because your model requires periodic updates and retraining procedures. Plan ahead instead of waiting for regulatory pressure to obtain approval, as regulators might force you to submit for new approval. A <strong>Predetermined Change Control Plan (PCCP)<\/strong> should be developed to specify expected model updates. This will avoid the need for FDA approval for minor modifications.<\/p>\n\n\n\n<p>You need to establish when model retraining will occur and the validation process that must be completed before system deployment. A roadmap system can help you proactively plan updates, reducing future regulatory discussions while avoiding unexpected compliance issues.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-for-healthcare-startups-entrepreneurs-in-digital-health\"><span class=\"ez-toc-section\" id=\"For_Healthcare_Startups_Entrepreneurs_in_Digital_Health\"><\/span>For Healthcare Startups (Entrepreneurs in Digital Health)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Building a product takes priority for startup owners who delay thinking about regulations until later. Using that strategy in healthcare operations leads to rapid negative consequences. The compliance process goes beyond bureaucratic requirements because it ensures your AI tool meets safety standards and market success requirements.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-make-compliance-part-of-your-business-plan\"><span class=\"ez-toc-section\" id=\"Make_Compliance_Part_of_Your_Business_Plan\"><\/span>Make Compliance Part of Your Business Plan<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Healthcare AI requires regulatory approval, which requires companies to delay their <strong>Minimum Viable Product (MVP)<\/strong> launch for an extended period. The FDA clearance process requires 6\u201312 months (or longer) for application preparation and submission. The presence of a defined regulatory framework will act as a positive factor for investors and stakeholders because it decreases business risk and demonstrates product durability.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-set-up-a-quality-system-from-day-one\"><span class=\"ez-toc-section\" id=\"Set_Up_a_Quality_System_From_Day_One\"><\/span>Set Up a Quality System From Day One<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>You don\u2019t need an overly complex Quality Management System (QMS) when you are just starting out, but having some basic standard operating procedures (SOPs) and documentation practices early on will save you a lot of time later. The FDA expects a design history file (documenting how your product was developed), a risk analysis (identifying potential safety concerns), and testing reports (showing how well your product performs). Many startups adhere to <strong>ISO 13485 certification<\/strong>, the industry standard for medical devices, as a guideline for developing a structured QMS. If you begin early, you won\u2019t be scrambling to assemble months\u2019 worth of documentation at the last minute.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-leverage-guidance-and-predicate-devices\"><span class=\"ez-toc-section\" id=\"Leverage_Guidance_and_Predicate_Devices\"><\/span>Leverage Guidance and Predicate Devices<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The FDA has granted clearance to devices powered by AI and machine learning, creating excellent opportunities for startup ventures. Startups should analyze existing products that have received FDA approval rather than developing new ones. The FDA database of AI medical devices is a vital resource offering valuable information. Review the FDA clearance process for a predicate device similar to your product. Whenever the FDA provides guidance for your device type, you must adhere to it precisely as stated during clinical testing. Demonstrating compliance with existing regulatory standards streamlines the approval process.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-conduct-user-centric-and-clinical-testing\"><span class=\"ez-toc-section\" id=\"Conduct_User-Centric_and_Clinical_Testing\"><\/span>Conduct User-Centric and Clinical Testing<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Your AI performs flawlessly in laboratory conditions, but regulators and customers demand to see its performance in authentic settings. Consider organizing beta tests and pilot studies that generate clinically significant data. Additionally, your startup can gain access to genuine patient data by teaming up with medical facilities or research organizations. The close collaboration between your AI system and medical practitioners enables you to discover operational problems and safety issues which make your AI system practical for clinical use.<\/p>\n\n\n<div class=\"post-cta\"><div><div><p class=\"blog-cta-title\">Redefine Your Project with Our Development Teams<\/p><p>Fuel Your Projects with Tailored Software Development Expertise<\/p><a href=\"https:\/\/hypersense-software.com\/services\/development-teams\">Get Your Development Team<\/a><\/div><\/div><\/div>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-be-honest-and-transparent-in-your-marketing\"><span class=\"ez-toc-section\" id=\"Be_Honest_and_Transparent_in_Your_Marketing\"><\/span>Be Honest and Transparent in Your Marketing<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>The biggest mistake startups make is promising their AI capabilities beyond what they can actually deliver. Using an FDA-cleared device to detect pneumonia does not permit marketing it as a COVID-19 diagnostic without completing the necessary approval processes for that specific purpose. Exaggerated claims can mislead customers and erode trust, trigger FDA warning letters, lead to delays in business operations, and damage the company\u2019s reputation with regulatory bodies and healthcare providers.<\/p>\n\n\n\n<p>When you find a problem affecting your AI systems, you need to act immediately. This can involve transparent communication, product updates, and possibly product recalls. Early problem resolution is superior to any attempt to hide the issue.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-compliance-as-a-pathway-to-innovation\"><span class=\"ez-toc-section\" id=\"Compliance_as_a_Pathway_to_Innovation\"><\/span>Compliance as a Pathway to Innovation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Although achieving FDA compliance for AI healthcare tools and electronic health records (EHRs) initially appears complex, it is essential for healthcare professionals who aim to produce meaningful healthcare outcomes. Success requires understanding all the rules, starting with device classification and ending with AI-specific guidance.<\/p>\n\n\n\n<p>The FDA collaboration process, combined with thorough validation procedures, led to IDx-DR, a transformative breakthrough in medical patient care. IBM Watson for Oncology illustrates how bypassing regulatory oversight can result in a loss of trust and product failures, even when the system launches successfully.<\/p>\n\n\n\n<p>Therefore, implementing AI tools requires more than just administrative procedures; it hinges on patient and clinical benefits. Healthcare innovators who actively engage with regulators and incorporate regulations early on can transform regulatory requirements into opportunities for creating safer and more effective digital health solutions that gain widespread trust.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-takeaways\"><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>If your AI influences <strong>clinical decisions<\/strong>, it likely requires FDA oversight.<\/li>\n\n\n\n<li>Most AI tools follow the <strong>Class II (510(k))<\/strong> pathway, but novel tech may need <strong>De Novo approval<\/strong>.<\/li>\n\n\n\n<li>AI regulations are evolving, especially regarding <strong>self-learning algorithms<\/strong>.<\/li>\n\n\n\n<li>Case studies show that <strong>early compliance planning leads to success<\/strong>, while shortcuts can be costly.<\/li>\n\n\n\n<li>FDA compliance is <strong>a trust signal<\/strong> that ensures AI is safe and effective.<\/li>\n\n\n\n<li>Following best practices leads to product development that both patients and doctors can depend on.<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-ub-content-toggle wp-block-ub-content-toggle-block\" id=\"ub-content-toggle-block-14810227-11c8-488c-bde1-64f8be163fa4\" data-mobilecollapse=\"false\" data-desktopcollapse=\"false\" data-preventcollapse=\"false\" data-showonlyone=\"true\">\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-0-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">How does the FDA 510(k) clearance process work for AI\/ML medical devices?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-0-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The 510(k) process is the most common FDA clearance pathway for Class II medical devices, including many AI tools. It requires the developer to demonstrate that their product is \u201csubstantially equivalent\u201d to an existing FDA-cleared device, known as a predicate. For AI\/ML software, this often includes similar functionality, risk profile, and performance characteristics.<\/p>\n\n\n\n<p>While 510(k) does not always require clinical trials, developers must submit technical documentation, software validation, cybersecurity measures, and risk assessments. The FDA typically reviews 510(k) submissions within 90 to 180 days, although timelines can vary based on the completeness of the application and complexity of the device.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-1-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">What are Class I, II, and III device classifications under the FDA for AI healthcare software?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-1-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The FDA classifies medical devices based on their risk level:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Class I (Low Risk):\u00a0Includes tools like wellness apps or basic record systems. Often exempt from premarket review.<\/li>\n\n\n\n<li>Class II (Moderate Risk):\u00a0Encompasses most AI diagnostic support tools (e.g., radiology imaging AI). Requires 510(k) clearance.<\/li>\n\n\n\n<li>Class III (High Risk):\u00a0Reserved for life-sustaining or autonomous AI tools (e.g., robotic surgery systems). Requires the rigorous Premarket Approval (PMA) process with clinical trials.<\/li>\n<\/ul>\n\n\n\n<p>Most AI\/ML medical software is classified as Class II unless it performs autonomous clinical decision-making without physician oversight, which may elevate it to Class III.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-2-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">How do I know if my AI healthcare software qualifies as a medical device under FDA rules?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down open\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"true\" class=\"wp-block-ub-content-toggle-accordion-content-wrap\" id=\"ub-content-toggle-panel-2-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>If your AI software is intended to diagnose, cure, mitigate, treat, or prevent disease, it likely qualifies as a medical device. This includes AI modules in EHRs that interpret patient data or generate treatment recommendations.<\/p>\n\n\n\n<p>Under the 21st Century Cures Act, certain administrative and wellness software functions (e.g., appointment scheduling or fitness tracking) are excluded from regulation. However, any software that influences clinical decisions or operates autonomously typically falls under FDA oversight and requires regulatory clearance or approval.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-3-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">How long does FDA clearance (510(k) or De Novo) take for an AI medical device?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-3-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The clearance timeline varies by regulatory pathway:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>510(k):\u00a0Generally takes\u00a090\u2013180 days, though the average review period (as of 2024\u20132025) is around\u00a0125\u2013140 FDA days\u00a0depending on submission quality.<\/li>\n\n\n\n<li>De Novo:\u00a0For novel devices without a predicate, this pathway takes longer\u2014typically\u00a06\u201312 months, due to increased scrutiny and required supporting evidence.<\/li>\n\n\n\n<li>PMA:\u00a0For high-risk devices, the Premarket Approval process may take\u00a012\u201318 months or longer, including time for clinical trial design, execution, and review.<\/li>\n<\/ul>\n\n\n\n<p>Planning ahead with a regulatory roadmap is crucial to align FDA timelines with product development and launch goals.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-4-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">Do all AI-powered EHR features need FDA approval?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-4-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>Not all. The FDA does not regulate EHR platforms themselves unless they include specific functionalities that fall under the definition of a medical device.<\/p>\n\n\n\n<p>An EHR system that simply stores or displays patient records is typically exempt. However, if the EHR integrates AI modules that analyze patient data, detect conditions, or recommend treatments, those components may be subject to FDA regulation. Whether the AI influences clinical decision-making is the deciding factor.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-5-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">What is the FDA\u2019s stance on self-learning AI\/ML models in medical devices?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-5-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The FDA acknowledges the unique challenge of regulating adaptive AI. Traditional approvals assume a static device, while AI models often learn and evolve after deployment. To address this, the FDA proposes the use of\u00a0Predetermined Change Control Plans (PCCPs)\u2014outlining anticipated model updates at the time of initial submission.<\/p>\n\n\n\n<p>This enables pre-authorized updates (e.g., retraining on new data) without requiring a full resubmission. However, any unscheduled or risky modifications still need additional review to ensure safety and performance are maintained.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-6-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">What are Good Machine Learning Practices (GMLP) for FDA-regulated AI healthcare tools?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-6-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>GMLP is a set of principles jointly defined by the FDA, Health Canada, and MHRA to guide the ethical and safe development of AI in healthcare. Key components include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Use of high-quality, diverse training data to reduce bias.<\/li>\n\n\n\n<li>Transparent, explainable AI outputs to support clinical interpretation.<\/li>\n\n\n\n<li>Continuous monitoring of AI performance post-deployment.<\/li>\n\n\n\n<li>Documentation of design decisions, risk assessments, and validation metrics.<\/li>\n<\/ul>\n\n\n\n<p>Following GMLP helps developers build trustworthy AI systems and supports regulatory confidence in software reliability.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-7-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">How does the FDA handle post-market monitoring of AI\/ML healthcare tools?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-7-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>Post-market monitoring is critical for AI tools that may behave unpredictably in real-world scenarios. The FDA expects manufacturers to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Track real-world performance data.<\/li>\n\n\n\n<li>Implement mechanisms to receive clinician feedback and error reports.<\/li>\n\n\n\n<li>Provide timely software updates or patches.<\/li>\n\n\n\n<li>Report adverse events or issues through the FDA\u2019s\u00a0MedWatch\u00a0program.<\/li>\n<\/ul>\n\n\n\n<p>This surveillance helps detect algorithm drift, unexpected failure modes, and safety risks that may not have been evident during premarket testing, especially for tools cleared via the 510(k) pathway.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-8-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">When should I consider the De Novo pathway for a novel AI\/ML medical device?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-8-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>Choose the De Novo pathway if your AI device is\u00a0low to moderate risk\u00a0but has\u00a0no predicate device\u00a0on the market. This is common for first-of-its-kind AI innovations that can&#8217;t reference existing approvals.<\/p>\n\n\n\n<p>The De Novo process establishes a new regulatory classification, enabling future 510(k) submissions to use your device as a predicate. This pathway involves more extensive documentation and clinical evidence than 510(k), but it&#8217;s often the only route for groundbreaking AI applications.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-9-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">How can I engage with the FDA (Pre-Submission) before submitting my AI healthcare tool?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-9-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The FDA offers a\u00a0Q-Submission (Pre-Sub) Program\u00a0for companies to consult with the agency prior to formal submission. This allows you to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Get feedback on testing plans, risk assessments, and intended use.<\/li>\n\n\n\n<li>Clarify device classification and pathway eligibility.<\/li>\n\n\n\n<li>Reduce risk of delays or rejections in your final application.<\/li>\n<\/ul>\n\n\n\n<p>Although Pre-Sub feedback is non-binding, it provides valuable insight into FDA expectations and helps streamline the regulatory journey.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-10-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">What quality standards (ISO 13485, ISO 14971) should I follow during AI medical device development?\u00a0<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-10-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>FDA-regulated software must follow a\u00a0Quality Management System (QMS)\u00a0aligned with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ISO 13485:\u00a0General quality management for medical devices.<\/li>\n\n\n\n<li>ISO 14971:\u00a0Risk management in product design and development.<\/li>\n<\/ul>\n\n\n\n<p>These standards require documentation of design decisions, verification and validation processes, traceability of requirements, and post-market corrective actions. Adopting these frameworks early reduces development errors, supports regulatory approval, and ensures product reliability.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-11-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">What are the biggest compliance risks for AI tools in healthcare?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-11-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>The most common compliance pitfalls include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Overpromising AI capabilities\u00a0in marketing or documentation.<\/li>\n\n\n\n<li>Lack of transparency\u00a0in how decisions are made (black-box models).<\/li>\n\n\n\n<li>Inadequate real-world testing\u00a0prior to deployment.<\/li>\n\n\n\n<li>Failure to define the intended use and scope\u00a0of the AI system.<\/li>\n\n\n\n<li>Skipping FDA clearance\u00a0for features that influence clinical care.<\/li>\n<\/ul>\n\n\n\n<p>Avoiding these risks requires early engagement with FDA guidance, clear product scope, ethical marketing, and adherence to validation protocols.<\/p>\n\n<\/div>\n\t\t<\/div>\n\n<div class=\"wp-block-ub-content-toggle-accordion\" style=\"border-color: #f1f1f1;\" id=\"ub-content-toggle-panel-block-\">\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-title-wrap\" style=\"background-color: #f1f1f1;\" aria-controls=\"ub-content-toggle-panel-12-14810227-11c8-488c-bde1-64f8be163fa4\" tabindex=\"0\">\n\t\t\t<p class=\"wp-block-ub-content-toggle-accordion-title ub-content-toggle-title-14810227-11c8-488c-bde1-64f8be163fa4\" style=\"color: #000000; \">As a startup, how early should I think about FDA compliance for AI healthcare tools?<\/p>\n\t\t\t<div class=\"wp-block-ub-content-toggle-accordion-toggle-wrap right\" style=\"color: #000000;\"><span class=\"wp-block-ub-content-toggle-accordion-state-indicator wp-block-ub-chevron-down\"><\/span><\/div>\n\t\t<\/div>\n\t\t\t<div role=\"region\" aria-expanded=\"false\" class=\"wp-block-ub-content-toggle-accordion-content-wrap ub-hide\" id=\"ub-content-toggle-panel-12-14810227-11c8-488c-bde1-64f8be163fa4\">\n\n<p>Immediately. FDA regulations should shape your\u00a0product design, development timeline, and go-to-market strategyfrom day one. The regulatory process can take 6\u201312 months or more, and failing to plan for it can delay funding, commercialization, or even lead to costly redesigns.<\/p>\n\n\n\n<p>Early-stage startups should set up a lightweight QMS, define product claims carefully, and engage with regulatory advisors or the FDA via Pre-Sub. Compliance isn\u2019t just a hurdle\u2014it is a competitive advantage in healthtech.<\/p>\n\n<\/div>\n\t\t<\/div>\n<\/div>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AI is revolutionizing healthcare. From predictive analytics to diagnostics, robust FDA regulation ensures these innovations remain safe, effective, and widely trusted. Learn how to navigate compliance.<\/p>\n","protected":false},"author":11,"featured_media":5037,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[46,55,221],"tags":[],"class_list":["post-5030","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ai-machine-learning","category-digital-transformation","category-entrepreneurship-startups"],"featured_image_src":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg","author_info":{"display_name":"Gabriela Mihoci","author_link":"https:\/\/hypersense-software.com\/blog\/author\/gabriela-mihoci\/"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v26.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Navigating FDA Compliance for AI Healthcare Tools &amp; EHRs<\/title>\n<meta name=\"description\" content=\"Master FDA compliance for AI healthcare tools &amp; EHRs. Explore regulation, best practices, &amp; real-world examples to ensure safe, effective innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs\" \/>\n<meta property=\"og:description\" content=\"Master FDA compliance for AI healthcare tools &amp; EHRs. Explore regulation, best practices, &amp; real-world examples to ensure safe, effective innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\" \/>\n<meta property=\"og:site_name\" content=\"HyperSense Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hypersense.software\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-04T15:03:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T18:25:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/SM-1920x1080-Navigating-FDA-Compliance-for-AI-Powered-Healthcare-Tools-and-EHRs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriela Mihoci\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HyperSenseSoft\" \/>\n<meta name=\"twitter:site\" content=\"@HyperSenseSoft\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriela Mihoci\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"24 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\"},\"author\":{\"name\":\"Gabriela Mihoci\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/d20313f979c4c728207222a70e4d2197\"},\"headline\":\"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs\",\"datePublished\":\"2025-04-04T15:03:34+00:00\",\"dateModified\":\"2025-11-13T18:25:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\"},\"wordCount\":5437,\"publisher\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg\",\"articleSection\":[\"AI &amp; Machine Learning\",\"Digital Transformation\",\"Entrepreneurship &amp; Startups\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\",\"url\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\",\"name\":\"Navigating FDA Compliance for AI Healthcare Tools & EHRs\",\"isPartOf\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg\",\"datePublished\":\"2025-04-04T15:03:34+00:00\",\"dateModified\":\"2025-11-13T18:25:49+00:00\",\"description\":\"Master FDA compliance for AI healthcare tools & EHRs. Explore regulation, best practices, & real-world examples to ensure safe, effective innovation.\",\"breadcrumb\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage\",\"url\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg\",\"contentUrl\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hypersense-software.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#website\",\"url\":\"https:\/\/hypersense-software.com\/blog\/\",\"name\":\"HyperSense Blog\",\"description\":\"Latest software development trends and insights\",\"publisher\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hypersense-software.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#organization\",\"name\":\"HyperSense Software\",\"url\":\"https:\/\/hypersense-software.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/04\/logo-hypersense-512.svg\",\"contentUrl\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/04\/logo-hypersense-512.svg\",\"width\":64,\"height\":64,\"caption\":\"HyperSense Software\"},\"image\":{\"@id\":\"https:\/\/hypersense-software.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/hypersense.software\",\"https:\/\/x.com\/HyperSenseSoft\",\"https:\/\/www.instagram.com\/hypersensesoftware\/\",\"https:\/\/ro.pinterest.com\/HyperSenseSoft\/\",\"https:\/\/www.linkedin.com\/company\/hypersense-software\/\",\"https:\/\/www.behance.net\/hypersense\",\"https:\/\/www.youtube.com\/@hypersensesoftware\",\"https:\/\/github.com\/HyperSense-Software\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/d20313f979c4c728207222a70e4d2197\",\"name\":\"Gabriela Mihoci\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/10\/cropped-IMG_6652-96x96.jpg\",\"contentUrl\":\"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/10\/cropped-IMG_6652-96x96.jpg\",\"caption\":\"Gabriela Mihoci\"},\"description\":\"Gabriela is a seasoned professional with 14+ years of experience in the L&amp;D field. She enjoys helping her colleagues in discovering their strengths and blind spots. Her passion for writing blossomed into reality 5 years ago, convincing her to become an employer branding specialist. Beyond creating development programs and content, Gabriela is an avid mountain enthusiast who enjoys trail running. What sets her apart? She's not afraid to dive into the world of fixing cars, all while grooving to the beats of dubstep music. Gabriela is a dynamic person, blending her professional expertise with an appetite for adventure and continuous learning.\",\"url\":\"https:\/\/hypersense-software.com\/blog\/author\/gabriela-mihoci\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Navigating FDA Compliance for AI Healthcare Tools & EHRs","description":"Master FDA compliance for AI healthcare tools & EHRs. Explore regulation, best practices, & real-world examples to ensure safe, effective innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/","og_locale":"en_US","og_type":"article","og_title":"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs","og_description":"Master FDA compliance for AI healthcare tools & EHRs. Explore regulation, best practices, & real-world examples to ensure safe, effective innovation.","og_url":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/","og_site_name":"HyperSense Blog","article_publisher":"https:\/\/www.facebook.com\/hypersense.software","article_published_time":"2025-04-04T15:03:34+00:00","article_modified_time":"2025-11-13T18:25:49+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/SM-1920x1080-Navigating-FDA-Compliance-for-AI-Powered-Healthcare-Tools-and-EHRs.jpg","type":"image\/jpeg"}],"author":"Gabriela Mihoci","twitter_card":"summary_large_image","twitter_creator":"@HyperSenseSoft","twitter_site":"@HyperSenseSoft","twitter_misc":{"Written by":"Gabriela Mihoci","Est. reading time":"24 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#article","isPartOf":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/"},"author":{"name":"Gabriela Mihoci","@id":"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/d20313f979c4c728207222a70e4d2197"},"headline":"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs","datePublished":"2025-04-04T15:03:34+00:00","dateModified":"2025-11-13T18:25:49+00:00","mainEntityOfPage":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/"},"wordCount":5437,"publisher":{"@id":"https:\/\/hypersense-software.com\/blog\/#organization"},"image":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage"},"thumbnailUrl":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg","articleSection":["AI &amp; Machine Learning","Digital Transformation","Entrepreneurship &amp; Startups"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/","url":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/","name":"Navigating FDA Compliance for AI Healthcare Tools & EHRs","isPartOf":{"@id":"https:\/\/hypersense-software.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage"},"image":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage"},"thumbnailUrl":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg","datePublished":"2025-04-04T15:03:34+00:00","dateModified":"2025-11-13T18:25:49+00:00","description":"Master FDA compliance for AI healthcare tools & EHRs. Explore regulation, best practices, & real-world examples to ensure safe, effective innovation.","breadcrumb":{"@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#primaryimage","url":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg","contentUrl":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2025\/04\/img-doctors.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/hypersense-software.com\/blog\/2025\/04\/04\/navigating-fda-compliance-ai-healthcare-ehrs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hypersense-software.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Navigating FDA Compliance for AI-Powered Healthcare Tools and EHRs"}]},{"@type":"WebSite","@id":"https:\/\/hypersense-software.com\/blog\/#website","url":"https:\/\/hypersense-software.com\/blog\/","name":"HyperSense Blog","description":"Latest software development trends and insights","publisher":{"@id":"https:\/\/hypersense-software.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hypersense-software.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hypersense-software.com\/blog\/#organization","name":"HyperSense Software","url":"https:\/\/hypersense-software.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hypersense-software.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/04\/logo-hypersense-512.svg","contentUrl":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/04\/logo-hypersense-512.svg","width":64,"height":64,"caption":"HyperSense Software"},"image":{"@id":"https:\/\/hypersense-software.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/hypersense.software","https:\/\/x.com\/HyperSenseSoft","https:\/\/www.instagram.com\/hypersensesoftware\/","https:\/\/ro.pinterest.com\/HyperSenseSoft\/","https:\/\/www.linkedin.com\/company\/hypersense-software\/","https:\/\/www.behance.net\/hypersense","https:\/\/www.youtube.com\/@hypersensesoftware","https:\/\/github.com\/HyperSense-Software"]},{"@type":"Person","@id":"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/d20313f979c4c728207222a70e4d2197","name":"Gabriela Mihoci","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hypersense-software.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/10\/cropped-IMG_6652-96x96.jpg","contentUrl":"https:\/\/hypersense-software.com\/blog\/wp-content\/uploads\/2023\/10\/cropped-IMG_6652-96x96.jpg","caption":"Gabriela Mihoci"},"description":"Gabriela is a seasoned professional with 14+ years of experience in the L&amp;D field. She enjoys helping her colleagues in discovering their strengths and blind spots. Her passion for writing blossomed into reality 5 years ago, convincing her to become an employer branding specialist. Beyond creating development programs and content, Gabriela is an avid mountain enthusiast who enjoys trail running. What sets her apart? She's not afraid to dive into the world of fixing cars, all while grooving to the beats of dubstep music. Gabriela is a dynamic person, blending her professional expertise with an appetite for adventure and continuous learning.","url":"https:\/\/hypersense-software.com\/blog\/author\/gabriela-mihoci\/"}]}},"_links":{"self":[{"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/posts\/5030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/comments?post=5030"}],"version-history":[{"count":5,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/posts\/5030\/revisions"}],"predecessor-version":[{"id":5432,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/posts\/5030\/revisions\/5432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/media\/5037"}],"wp:attachment":[{"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/media?parent=5030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/categories?post=5030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hypersense-software.com\/blog\/wp-json\/wp\/v2\/tags?post=5030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}